Lyme Disease Testing Explained: How Two-Tier Testing Works and When to Test After a Tick Bite

Before any discussion of tests: if you have an expanding circular rash around a tick bite — the classic erythema migrans "bullseye," typically appearing 3–30 days after the bite — see a clinician promptly rather than ordering a blood test. That rash is considered diagnostic on its own, and treatment decisions for it don't wait on blood work. Early in infection, antibody tests are at their least sensitive, so a negative result at rash stage can be false reassurance at exactly the wrong moment.

Blood testing earns its keep in the other scenarios: a known bite without a rash, unexplained fevers, joint pain, or fatigue after time in tick country, or a clinician working up symptoms weeks after possible exposure.

The CDC-recommended algorithm runs two different antibody tests in sequence, and the design makes sense once you see what each is good at:

• Tier 1 — the ELISA screen. Highly sensitive: it rarely misses antibodies that are present, but it sometimes flags antibodies that aren't Lyme-specific (other infections, even autoimmune activity, can cross-react). A negative ELISA at the right timing window is strong evidence against Lyme; a positive one is a maybe.
• Tier 2 — the Western blot confirmation. Highly specific: it separates true Lyme antibodies from cross-reactions by looking at the exact protein bands your antibodies bind. It only runs when tier 1 is positive or equivocal — that's the "reflex."

A "with reflex" test wires both tiers to one blood draw: if your screen is positive, the confirmatory blot runs automatically from the same sample — no second appointment, no separate order. The result you act on is the combination: only a positive screen plus a positive blot counts as a positive two-tier result.

Both tiers look at two antibody classes, and their timing is the key to reading results:

• IgM — the early responder, typically detectable a few weeks after infection and fading over months. Because IgM is the less specific class, an IgM-only positive long after a possible exposure (roughly beyond the first 4–6 weeks) is treated with caution — at that point a true infection should have IgG present too.
• IgG — the durable responder, usually detectable from about 4–6 weeks onward, and often persisting for years after successful treatment.

That persistence cuts both ways: it's why a positive IgG in someone treated years ago doesn't mean reinfection — and why serology can't be used as a "test of cure" after treatment. Antibodies are a record that your immune system met the bacterium, not a live infection meter.

More than the assay, more than the lab — when you test determines whether the answer means anything:

• First ~2 weeks after a bite: antibody tests are unreliable — your immune system hasn't produced measurable antibodies yet, and false negatives are common. If you're symptomatic in this window, that's a clinician conversation, not a serology order. (PCR-based "acute tick-borne panels" exist for this window — they detect pathogen DNA rather than antibodies, cost several times more, and answer a different question.)
• 4–6 weeks after exposure: the reliable window for two-tier serology, and when most people should test.
• Tested early and negative, symptoms persist: retest at the 4–6 week mark — an early negative doesn't close the question.

Positive two-tier result (screen positive, blot positive): evidence of Lyme antibodies. With current symptoms, that's a treatment conversation with a clinician. Without symptoms — especially with a history of treated Lyme — it may reflect the years-long persistence of IgG rather than active infection; interpretation belongs to a clinician who can see the whole picture.

Negative screen at 6+ weeks after exposure: Lyme becomes an unlikely explanation for ongoing symptoms — the two-tier algorithm is specifically designed so that established infection is very hard to miss at that point. The productive next step is a clinician conversation about other causes, not a longer chain of Lyme tests.

Positive screen, negative blot: the two-tier result is negative — this is the cross-reaction pattern the second tier exists to catch.

A few presentations after a possible tick exposure shouldn't wait on any mail-order lab result. Seek prompt medical evaluation for:

• Facial drooping or weakness on one side of the face
• Severe headache with a stiff neck
• Heart symptoms — palpitations, fainting, lightheadedness, chest pain
• Multiple expanding rashes, or a rash with fever that's making you feel significantly ill
• A significantly swollen, painful joint

These can represent disseminated Lyme disease (or something else urgent), and the evaluation-and-treatment decision is clinical. Testing may well be part of it — ordered in a context where the result gets acted on immediately.

The Lyme Disease Serology with Reflex is $64.99 on TestWell — the complete CDC two-tier algorithm from one draw, with the confirmatory Western blot included in the price rather than billed separately if your screen is positive. No fasting, no insurance, no referral: a licensed physician reviews your order, you walk into a nearby lab, and results arrive in 3–7 business days. You can order lab tests online today and draw tomorrow.

Deciding whether testing is worth it for your situation? The Lyme test decision guide covers who benefits — and if you're comparing antibody-test options on price, the cost breakdown on the test page does the bundled-vs-separate math.